WEIGHT LOSS
How Much Weight Can You Lose in a Month?
Why weight loss varies, what realistic progress looks like, and why a safe plan matters more than a dramatic first month.
Weight loss varies substantially from person to person, and a responsible medical service should be honest about that. The first month of treatment — whether with GLP-1 medicines, dietary change, or a combination — often produces the most visible change, but much of the early drop can reflect fluid shifts and reduced food volume rather than fat loss. Clinically meaningful weight loss takes longer to assess and should be measured over months rather than weeks.
Adherence, dose escalation, side effects, nutritional intake, sleep, activity, alcohol, and co-existing medical factors all influence how much weight a patient loses and how quickly.
ON THIS PAGE
What realistic progress looks like
For patients on GLP-1 medicines such as Mounjaro or Wegovy, the dose is titrated gradually over several weeks. During the early titration phase, appetite reduction begins but the full weight-loss effect is not yet reached. Most clinical trials measure outcomes at 6 to 12 months rather than 4 weeks. A safe and sustainable rate of weight loss in the context of medical treatment is generally 0.5 to 1kg per week once the dose is established — though some patients lose more and some less. What matters clinically is the overall trajectory, not any single weekly measurement.
Beyond the scales
Why the number on the scales is not the only marker
For some patients, success means a large drop in body weight. For others, it means meaningful appetite control, improvement in blood pressure, reduced waist circumference, better sleep, improved mobility, or more stable blood sugar. These are clinically important outcomes even if the scale does not move as dramatically as expected. Patients with higher starting weights often see larger absolute losses. Patients closer to the threshold may see smaller but still clinically relevant changes — particularly in metabolic markers that influence long-term cardiovascular risk.
Same-day appointments available. Book online or call 020 7736 7557.
Adjusting the plan
When weight loss is slower than expected
Patients who are not losing weight as expected should not simply conclude that treatment has failed. Slower progress may reflect a dose that has not yet reached the therapeutic level, ongoing factors such as poor sleep, high stress, alcohol intake, or medication effects, or an underlying metabolic issue that needs investigating. Sometimes broader investigation through health checks or blood tests — including thyroid function, HbA1c, and hormonal markers — is the right next step. A GP who is monitoring your treatment can adjust the plan rather than leaving you to interpret the numbers alone.
Common questions
Is there a realistic range of weight loss in the first month?
Weight loss varies substantially between patients. The first month often produces the most visible change, but much of the early drop reflects fluid shifts and reduced food volume rather than fat loss. A safe and sustainable rate once the dose is established is generally 0.5–1kg per week — though some lose more and some less. Clinical trials measure outcomes over 6–12 months, not 4 weeks.
Why does the scale sometimes not move despite taking the medication?
Dose may not yet be at therapeutic level during titration, and individual response varies. Sleep, stress, alcohol, medication effects, and underlying metabolic factors all influence the result. A plateau or slower-than-expected progress is not necessarily treatment failure — it is a signal for the GP to reassess rather than assume.
Are there markers of progress other than the scale?
Yes. Appetite reduction, improvement in blood pressure, reduced waist circumference, better sleep, improved mobility, and more stable blood sugar are all clinically important outcomes even when scale change is modest. Patients with higher starting weights often see larger absolute losses; smaller changes can still be clinically relevant.
FURTHER READING